Form 4 for BIIB Biogen
Accepted 2024-09-05 00:00:00 ET · period of report 2024-08-30 · accession 0001127602-24-023505 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-05 | 2024-08-30 | BIIB | Singhal Priya | Head of Development | F - Tax | $204.76 | -807 | 5,747 | -12% | -$165.2K |
| D | 2024-09-05 | 2024-08-30 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | +1,668 | 6,554 | +34% | $0 |
| D | 2024-09-05 | 2024-09-03 | BIIB | Singhal Priya | Head of Development | S - Sale+OE | $204.22 | -431 | 5,316 | -7% | -$88.0K |
| D | 2024-09-05 | 2024-08-30 | BIIB | Singhal Priya | Head of Development | M - OptEx | $0.00 | -1,668 | 1,669 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | F | D | 807 | $204.76 | 5,747.48 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-30 | M | A | 1,668 | $0.00 | 6,554.48 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-03 | S | D | 431 | $204.22 | 5,316.48 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2024-08-30 | M | D | 1,668 | $0.00 | 1,669 | D | $0.00 · — to 2025-09-01 | 1,668 Common Stock | (F1) This award was granted to the reporting person on September 1, 2022 and will vest in three equal installments on each anniversary of the grant date. |